Skip to content
#large language models Dataset Open access

A2H_Preclinical_Translation_Data

Sep 2026 · Zenodo (CERN European Organization for Nuclear Research)

Abstract

🧾 Description This dataset accompanies the study “Large-Scale Assessment of Animal-to-Human Drug Translation Using Natural Language Processing” (bioRxiv, DOI: 10.64898/2026.05.20.726540), which presents a computational framework for the large-scale assessment of animal-to-human translation in drug development, with a focus on the neuroscience domain. The dataset contains the data products underlying this framework and integrates evidence extracted from biomedical literature with clinical trial and regulatory information using natural language processing (NLP) methods. It supports analyses of the progression of drugs and drug–disease pairs from preclinical animal studies into clinical development and regulatory approval, as well as analyses of preclinical study characteristics associated with translational outcomes. The dataset is organized according to the multi-stage processing pipeline used in the study, including PubMed search results, filtered animal studies, named entity recognition (NER) outputs, entity normalization and linking, extraction of experimental and reporting characteristics, and final datasets used for animal-to-human translation analyses. 🎯 Potential uses This dataset can be used to: Study large-scale patterns of animal-to-human translation Analyze experimental design factors associated with translational success Support automated evidence synthesis in biomedical research Develop and evaluate NLP methods for biomedical information extraction Investigate trends in preclinical neuroscience research Key components include: Information Classification / Extraction Models (models/): The folder contains all trained models used in the preclinical evidence extraction pipeline. It includes the SciBERT-based binary classifier for animal-study identification and fine-tuned NER models for extracting animal numbers, strains, and drug–disease entities. The individual model directories also contain the corresponding model weights, tokenizer and configuration files, and training and evaluation outputs. PubMed full Neuro data (01_pubmed_query_neuro/): This directory contains raw literature records retrieved from PubMed across multiple query rounds. data/pubmed_queries/union_all_queries_pmids_21704840.txt: the PMIDs of all articles retrieved from the neuropsychiatric queries. data/full_pubmed_raw: Raw literature retrieved from PubMed in multiple query rounds. Each file consists of line-based entries, where each line represents one publication record. Fields are separated using a triple-pipe delimiter. The records follow the schema: ||| ||| ||| ||| ||| Animal study classification (02_animal_study_classification/): This directory contains data and model outputs for identifying and curating animal studies from PubMed. data/animal_studies/ Filtered PubMed metadata for animal studies. model_predictions/ Cleaned and aggregated prediction outputs for animal study classification, including intermediate and final datasets. pubmed_results/, pubmed_results_r2/, pubmed_results_r3/...Results from multiple PubMed query rounds. Later rounds (e.g., `r3`) include chunked prediction outputs. Information extraction (NER) (03_IE_ner/): This directory contains datasets and model outputs for named entity recognition (NER) on animal studies. data/animal_studies_with_drug_disease/ Metadata for animal studies enriched with drug and disease information. data/finetuning_ner/ Datasets used for NER model training and evaluation, including: animals_nr/, drug_disease/, strain/: domain-specific annotated datasets (JSON format) k_fold_splits/: cross-validation splits for each dataset model_predictions/ Model outputs for NER tasks, organized by entity type (e.g., drug–disease), stored as chunked CSV files. Entity normalization (04_normalization/): This directory contains normalized entity mappings for diseases and drugs extracted from animal studies. data/mapped_all/entities_drug_disease_preclin.csv Combined dataset of extracted drug and disease entities with normalization, including:- PMID: document identifier - disease_*: disease mentions mapped to MONDO terms and IDs - drug_*: intervention mentions mapped to UMLS terms and IDs - merged_*: consolidated normalized labels and identifiers - nearest_dataset_parent_*: hierarchy-based parent mappings (if available) Model predictions (08_IE_full_text/model_predictions/) This directory contains document-level predictions and metadata extracted from full-text articles. animals_nr/Extracted total counts of animals and converted to numeric where possible. regex/Rule-based (regex) document-level predictions for key reporting features, including:assay, blinding, randomization, sample, sample size, sex, species, and welfare. strain/Extracted and normalized animal strain information. author_affiliations_pubmed_mapped.csv Maps PubMed records to author affiliations (e.g., institutions, countries). full_text_combined_all_annotations_metadata.csvAggregated dataset combining full-text annotations, predictions, and metadata across pipelines. Translation analysis (10_drug_disease_translation_analysis/): out/ Final translation association datasets, including full and subset-specific outputs (e.g., NEURO). interm_drug_disease_pairs/ Intermediate processed drug–disease pairs, including: aggregated (agg) and flat annotation formats translation tables linking drug–disease pairs across datasets Key Files translation_table_drug_disease_*.csv: Core mapping table linking normalized drug–disease pairs across datasets. drug_disease_pairs_annotations_*.csv: Annotated drug–disease pairs in both flattened (each PMID a seaparate row) formats, and aggregated. Aggregated preclinical evidence per drug–disease pair includes:- animal characteristics (sex, species, strain)- assay types- country of first author- supporting PMIDs- counts of articles and reporting quality indicators (blinding, randomization, welfare) df_translation_associations_*.csv: Feature table for modeling (e.g., logistic regression), where each row represents a drug–disease pair. Includes aggregated features from preclinical studies, such as:- experimental design signals (blinding, randomization, welfare)- diversity metrics (species, strain, assay, country)- article counts - target: outcome variable for translation analysis

View source

Similar papers

#computer vision Open access Jun 2016

Software Development in Startup Companies: The Greenfield Startup Model

The results are packaged in the Greenfield Startup Model (GSM), which explains the priority of startups to release the product as quickly as possible, and the need to shorten time-to-market, by speeding up the development through low-precision engineering activities.

Carmine Giardino, Nicolò Paternoster, M. Unterkalmsteiner et al. · 178 citations · ⚡14
#computer vision Open access Oct 2016

Software Startups - A Research Agenda

Software startup companies develop innovative, software-intensive products within limited timeframes and with few resources, searching for sustainable and scalable business models.

M. Unterkalmsteiner, P. Abrahamsson, Xiaofeng Wang et al. · 157 citations · ⚡17
#machine learning Review Open access Oct 2016

“Failures” to be celebrated: an analysis of major pivots of software startups

This study conducts a case survey study based on the secondary data of the major pivots happened in 49 software startups, and demonstrates that customer need pivot is the most common among all pivot types.

Sohaib Shahid Bajwa, Xiaofeng Wang, Anh Nguyen-Duc et al. · 127 citations · ⚡15
#computer vision Review Open access May 2015

A survey study on major technical barriers affecting the decision to adopt cloud services

The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.

Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al. · 111 citations · ⚡8
#computer vision Conference Open access Dec 2013

Affordable and Energy-Efficient Cloud Computing Clusters: The Bolzano Raspberry Pi Cloud Cluster Experiment

The ongoing work building a Raspberry Pi cluster consisting of 300 nodes is presented, with potential use cases being an inexpensive and green test bed for cloud computing research and a robust and mobile data center for operating in adverse environments.

P. Abrahamsson, S. Helmer, Nattakarn Phaphoom et al. · 110 citations · ⚡7
#computer vision Book Open access Mar 2017

On the Unhappiness of Software Developers

The results indicate that software developers are a slightly happy population, but the need for limiting the unhappiness of developers remains, and 219 factors representing causes of unhappiness while developing software are identified.

D. Graziotin, Fabian Fagerholm, Xiaofeng Wang et al. · 84 citations · ⚡6

Related blog posts

MIT News · Artificial Intelligence Sep 14, 2026

New method enables AI for safety-critical situations

The “HardFlow” algorithm could help generative AI models produce high-quality outputs that obey strict requirements when “pretty close” doesn’t cut it.

GPT-Lab Sep 10, 2026

Responsible AI Must Consider Its Afterlife

AI may appear weightless, but every model depends on physical infrastructure. To understand responsible AI, we need to look beyond algorithms and consider the entire lifecycle of the hardware behind them. The post Responsible AI Must Consider Its Afterlife appeared first on GPT-Lab.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.